These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2653642)

  • 1. Cysteamine and the endocrine pancreas: immunocytochemical, immunochemical, and functional aspects.
    Ahrén B; Böttcher G; Ekman R; Sundler F
    Cell Tissue Res; 1989 Apr; 256(1):159-66. PubMed ID: 2653642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine exerts multiple effects on the endocrine cells of the rat pancreas.
    Ostenson CG; Efendić S
    Biochim Biophys Acta; 1985 Aug; 846(2):242-7. PubMed ID: 2862920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid depletion of somatostatin in isolated mouse pancreatic islets after treatment with cysteamine.
    Petersson B; Hellerström C
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):227-31. PubMed ID: 2865862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine-induced reduction in tissue somatostatin immunoreactivity is associated with alterations in somatostatin mRNA.
    Papachristou DN; Liu JL; Patel YC
    Regul Pept; 1994 Jan; 49(3):237-47. PubMed ID: 7908140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cysteamine administration on plasma concentration of metabolites, pancreatic glucagon and insulin in the chicken.
    Rideau N; Karmann H; Simon J
    Comp Biochem Physiol A Comp Physiol; 1990; 96(2):327-31. PubMed ID: 1976475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function.
    Sorenson RL; Grouse LH; Elde RP
    Diabetes; 1983 Apr; 32(4):377-9. PubMed ID: 6131850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cysteamine on the somatostatin content of guinea-pig islets.
    Petersson B
    Ups J Med Sci; 1987; 92(1):85-8. PubMed ID: 2884764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the depleting effect of cysteamine on pancreatic somatostatin.
    Hashimoto N; Kanatsuka A; Makino H; Sakurada M; Yoshida S
    Horm Metab Res; 1987 Jan; 19(1):11-4. PubMed ID: 2881872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cysteamine on canine splanchnic D-cells].
    Kawai K
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):962-72. PubMed ID: 6138285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of somatostatin deficiency on cell distribution within the Langerhans islets.
    Fujita Y; Amemiya H; Abe Y; Takada I; Ishii K; Yajima Y; Yamamoto N; Miyazawa H; Okabe H
    Diabetes Res Clin Pract; 1985-1986 Mar; 1(6):335-42. PubMed ID: 2873009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine-induced depletion of somatostatin in sheep: time course of depletion and changes in plasma metabolites, insulin, and growth hormone.
    McLeod KR; Harmon DL; Schillo KK; Mitchell GE
    J Anim Sci; 1995 Jan; 73(1):77-87. PubMed ID: 7601757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse.
    Dunning BE; Ahrén B
    Acta Physiol Scand; 1993 Oct; 149(2):215-9. PubMed ID: 7505518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of cysteamine: relationship to somatostatin depletion.
    Brown MR; Fisher LA; Sawchenko PE; Swanson LW; Vale WW
    Regul Pept; 1983 Jan; 5(2):163-79. PubMed ID: 6131501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-14-like antigenic sites in fixed islet D-cells are unaltered by cysteamine: a quantitative electron microscopic immunocytochemical evaluation.
    Patel YC; Ravazzola M; Amherdt M; Orci L
    Endocrinology; 1987 Apr; 120(4):1663-7. PubMed ID: 2881776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is somatostatin a true local inhibitory regulator of insulin secretion?
    Kanatsuka A; Makino H; Osegawa M; Kasanuki J; Suzuki T; Yoshida S; Horie H
    Diabetes; 1984 Jun; 33(6):510-5. PubMed ID: 6202577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
    McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
    Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of galanin on arginine-stimulated pancreatic hormone release from isolated perifused rat islets.
    Tajiri Y; Sako Y; Umeda F; Hisatomi A; Nawata H
    Horm Metab Res; 1990 Jan; 22(1):1-6. PubMed ID: 1689687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.